Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 0 | 53,811 | 3,181 | 5,392 | 4,116 |
| Gross Profit | 0 | 53,811 | 3,181 | 5,392 | 4,116 |
| Operating Expenses | 41,864 | 39,739 | 44,148 | 47,922 | 45,026 |
| Operating Income | -41,864 | 14,072 | -40,967 | -42,530 | -40,910 |
| Other Income | 3,060 | 1,802 | 2,149 | 2,688 | 3,289 |
| Pre-tax Income | -38,804 | 15,874 | -38,818 | -39,842 | -37,621 |
| Income Tax | -55 | -10 | 35 | 34 | 49 |
| Net Income Continuous | -38,749 | 15,884 | -38,853 | -39,876 | -37,670 |
| Net Income | $-38,749 | $15,884 | $-38,853 | $-39,876 | $-37,670 |
| EPS Basic Total Ops | -0.30 | 0.14 | -0.35 | -0.36 | -0.33 |
| EPS Basic Continuous Ops | -0.30 | 0.14 | -0.35 | -0.36 | -0.34 |
| EPS Diluted Total Ops | -0.29 | 0.13 | -0.35 | -0.36 | -0.33 |
| EPS Diluted Continuous Ops | -0.30 | 0.13 | -0.35 | -0.36 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.29 | 0.13 | -0.35 | -0.36 | -0.35 |
| EBITDA(a) | $-42,153 | $14,067 | $-41,064 | $-42,546 | $-41,146 |